MedPlus eases private-label drug push as customer resistance grows

Some employees may have pushed substitutions too aggressively. 'We've have asked them to stop at suggesting the alternatives available through the MedPlus brand... and leave the final decision to the customer,' CEO Madhukar Gangadi tells Moneycontrol